The cytokine language of monocytes and macrophages in systemic sclerosis

Arthritis Research and Therapy

Volumn 12, Issue 5, 2010, Pages

  Christmann, Romy B ^a   Lafyatis, Robert ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; ENDOTHELIN 1; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ANTIGEN EXPRESSION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; EDITORIAL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; PHENOTYPE; PROTEIN EXPRESSION; SYSTEMIC SCLEROSIS; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; NOTE; PATHOLOGY;

CYTOKINES; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; SCLERODERMA, SYSTEMIC;

EID: 77958587984     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3167     Document Type: Editorial

References (19)

1. Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, Yonemura Y, Komohara Y, Takeya M, Mitsuya H, Ihn H. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 2010, 12:R128. 2945018, 20602758, 10.1186/ar3066.
2. Kraling BM, Maul GG, Jimenez SA. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology 1995, 63:48-56. 10.1159/000163933, 7546275.
3. Rossi GA, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1985, 131:612-617.
4. Klareskog L, Gustafsson R, Scheynius A, Hallgren R. Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum 1990, 33:1534-1541. 10.1002/art.1780331011, 2171541.
5. Yamamoto T, Eckes B, Hartmann K, Krieg T. Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. J Dermatol Sci 2001, 26:133-139. 10.1016/S0923-1811(00)00169-9, 11378330.
6. Crestani B, Seta N, Palazzo E, Rolland C, Venembre P, Dehoux M, Boutten A, Soler P, Dombret MC, Kahn MF. Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994, 150(5 Pt 1):1363-1367.
7. Abraham DJ, Vancheeswaran R, Dashwood MR, Rajkumar VS, Pantelides P, Xu SW, du Bois RM, Black CM. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol 1997, 151:831-841. 1857854, 9284832.
8. Del Galdo F, Maul GG, Jimenez SA, Artlett CM. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. Arthritis Rheum 2006, 54:2616-2625. 10.1002/art.22010, 16868985.
9. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 2007, 56:1010-1020. 10.1002/art.22382, 17328080.
10. Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, Lafyatis R. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoSOne 2010,
11. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483. 10.1146/annurev.immunol.021908.132532, 19105661.
12. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686. 10.1016/j.it.2004.09.015, 15530839.
13. Lee PY, Li Y, Kumagai Y, Xu Y, Weinstein JS, Kellner ES, Nacionales DC, Butfiloski EJ, van Rooijen N, Akira S, Sobel ES, Satoh M, Reeves WH. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol 2009, 175:2023-2033. 10.2353/ajpath.2009.090328, 19808647, 2774066.
14. Sulahian TH, Högger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000, 12:1312-1321. 10.1006/cyto.2000.0720, 10975989.
15. Jozefowski S, Arredouani M, Sulahian T, Kobzik L. Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J Immunol 2005, 175:8032-8041.
16. Beamer CA, Holian A. Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am J Physiol Lung Cell Mol Physiol 2005, 289:L186-L195. 15849212, 10.1152/ajprenal.00234.2004.
17. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82. 10.1016/S1074-7613(03)00174-2, 12871640.
18. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest 2007, 117:89-93. 1716225, 17200712, 10.1172/JCI30992.
19. Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, Takehara K. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis 2005, 64:21-28. 1755178, 15608300, 10.1136/ard.2003.018705.